Cathay Biotech Inc. (SHA: 688065)
China flag China · Delayed Price · Currency is CNY
51.73
-0.28 (-0.54%)
Nov 13, 2024, 3:00 PM CST

Cathay Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Market Capitalization
30,07132,01235,74976,78635,439-
Upgrade
Market Cap Growth
-14.51%-10.45%-53.44%116.67%--
Upgrade
Enterprise Value
30,33431,82333,87871,14229,114-
Upgrade
Last Close Price
51.7354.7260.82130.0759.57-
Upgrade
PE Ratio
76.0286.8564.03127.5270.68-
Upgrade
PS Ratio
10.9415.1414.6432.4923.67-
Upgrade
PB Ratio
2.622.172.385.233.09-
Upgrade
P/FCF Ratio
-175.56-32.00-10.53-87.21-142.81-
Upgrade
P/OCF Ratio
38.6456.2244.48132.6968.82-
Upgrade
EV/Sales Ratio
10.9815.0513.8830.1019.45-
Upgrade
EV/EBITDA Ratio
50.3971.2750.43106.5351.48-
Upgrade
EV/EBIT Ratio
98.12192.2383.32142.5065.10-
Upgrade
EV/FCF Ratio
-192.70-31.81-9.98-80.80-117.32-
Upgrade
Debt / Equity Ratio
0.090.120.070.05-0.06
Upgrade
Debt / EBITDA Ratio
2.133.981.681.11-0.46
Upgrade
Debt / FCF Ratio
-8.25-1.78-0.33-0.84--1.98
Upgrade
Asset Turnover
0.150.120.140.170.170.35
Upgrade
Inventory Turnover
1.381.011.171.561.011.55
Upgrade
Quick Ratio
2.161.704.758.1416.891.42
Upgrade
Current Ratio
2.872.225.959.3619.422.60
Upgrade
Return on Equity (ROE)
2.60%2.74%4.12%4.84%5.67%12.28%
Upgrade
Return on Assets (ROA)
1.06%0.56%1.49%2.20%3.09%6.13%
Upgrade
Return on Capital (ROIC)
1.19%0.63%1.61%2.32%3.40%8.07%
Upgrade
Earnings Yield
1.32%1.14%1.55%0.77%1.29%-
Upgrade
FCF Yield
-0.52%-3.12%-9.50%-1.15%-0.70%-
Upgrade
Dividend Yield
0.37%0.35%0.30%0.25%0.96%-
Upgrade
Payout Ratio
35.32%37.58%37.39%57.11%0.85%25.34%
Upgrade
Buyback Yield / Dilution
-0.97%0.10%0.12%-7.38%-6.91%-1.57%
Upgrade
Total Shareholder Return
-0.60%0.45%0.41%-7.14%-5.95%-1.57%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.